News

Article

Long-Acting Injectables: Part 1 of a Conversation With Peter J. Weiden, MD

Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 1 of their conversation.

CONFERENCE REPORTER
Psychiatric Times Editor-in-Chief, John J. Miller, MD, sat down with his colleague, Peter J. Weiden, MD, of the State University of New York at Stony Brook at the 2024 American Psychiatric Association (APA) Annual Meeting. In part 1 of their conversation, Miller and Weiden discuss long-acting injectables then and now.

Dr Weiden is a professor at the State University of New York at Stony Brook.

See more coverage from the 2024 APA Annual Meeting in Psychiatric Times at https://www.psychiatrictimes.com/conferences/apa.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Videos
ty/Adobe Stock
Gus Alva, MD
Psychiatric Times Experts Weight in on FDA Advisory Decision for PTSD
sofiko14/Adobe Stock
Miquel/Adobe Stock
NAIMAH/Adobe Stock
crizzystudio/Adobe Stock
sebra/Adobe Stock
freshidea/Adobe Stock
© 2025 MJH Life Sciences

All rights reserved.